Eastside Therapeutic Resource, Inc. dba Core Clinical Research

Everett, Washington 98201-4077

0 studies enrolling now · 11 studies all time

What they study most

Attention Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder, Bipolar Disorder, Borderline Personality Disorder, Irritability Associated With Autism Spectrum Disorder, Major Depressive Disorder, Pediatric Migraine, Tourette Syndrome, Tourette Syndrome in Adolescence, Tourette Syndrome in Children

Studies at this site

• Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
• A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. — Completed
• Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients — Completed
• Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder — Stopped early
• Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder — Completed
• A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder — Completed
• Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension — Completed
• Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents — Completed
• Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children — Stopped early
• Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) — Stopped early
• Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder — Stopped early